Types and Management of Supraventricular Tachycardia (SVT)
Supraventricular tachycardia encompasses eight distinct types that originate above the ventricles, with catheter ablation being the most effective long-term management strategy for most symptomatic recurrent forms. 1, 2
The Eight Types of SVT
Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
- Most common form of SVT (50-60% of cases)
- Involves dual pathways within the AV node
- Typically presents with sudden onset/offset of symptoms
Atrioventricular Reentrant Tachycardia (AVRT)
- Involves an accessory pathway between atria and ventricles
- Includes Wolff-Parkinson-White syndrome (pre-excitation)
- Orthodromic (narrow QRS) or antidromic (wide QRS) variants
Atrial Tachycardia (AT)
- Focal or microreentrant mechanism in atrial tissue
- Can be automatic, triggered, or reentrant
- Often seen after atrial fibrillation ablation
Sinus Tachycardia
- Appropriate (physiologic) response to exercise/stress
- Inappropriate sinus tachycardia (IST) - abnormal elevation at rest
Sinus Nodal Reentry Tachycardia
- Reentry circuit within or near the sinus node
- Relatively uncommon form of SVT
Junctional Ectopic Tachycardia
- Originates from the AV junction
- More common in pediatric population or after cardiac surgery
Atrial Flutter
- Macro-reentrant circuit in atrium (typically right)
- Typical (counterclockwise) or atypical variants
- Regular "sawtooth" pattern on ECG
Multifocal Atrial Tachycardia
- Multiple atrial foci firing
- Irregular rhythm with ≥3 different P wave morphologies
- Often associated with pulmonary disease
Acute Management Algorithm
Step 1: Assess Hemodynamic Stability
- If unstable (hypotension, altered mental status, chest pain, heart failure):
Step 2: For Stable Patients
Vagal Maneuvers (first-line)
- Modified Valsalva maneuver (43% effective) 2
- Carotid sinus massage (in appropriate patients)
If vagal maneuvers fail, administer Adenosine IV
If adenosine fails:
- IV calcium channel blockers (diltiazem, verapamil) OR
- IV beta-blockers (metoprolol, esmolol)
- If still unsuccessful: synchronized cardioversion 1
Long-Term Management
First-Line Therapy
- Catheter ablation (94-98% success rate) 2
- Recommended for recurrent, symptomatic SVT
- Especially for AVNRT, AVRT, and focal AT
- Curative in most cases with low complication rate
Pharmacologic Options (if ablation declined/contraindicated)
AV nodal blocking agents:
- Beta-blockers (metoprolol, propranolol)
- Calcium channel blockers (diltiazem, verapamil)
Antiarrhythmic medications:
- Class IC: Flecainide, propafenone (in structurally normal hearts)
- Class III: Sotalol, amiodarone (reserved for refractory cases)
"Pill-in-pocket" approach 1, 4
- Single-dose oral medication taken at arrhythmia onset
- Option for infrequent, well-tolerated episodes
- Diltiazem/propranolol combination or flecainide
Special Considerations
Pregnancy
Acute management:
- Vagal maneuvers first
- Adenosine if needed (safe in pregnancy)
Chronic management: 1
- Beta-blockers (metoprolol, propranolol)
- Calcium channel blockers (verapamil)
- Ablation with minimal radiation if drug-refractory
Wolff-Parkinson-White Syndrome
- Higher risk of sudden cardiac death
- Catheter ablation strongly recommended
- Avoid AV nodal blockers alone (may accelerate conduction through accessory pathway)
Wide-Complex SVT
- May represent SVT with aberrancy or pre-excitation
- If uncertain, treat as ventricular tachycardia 1
- Diagnostic features of SVT with aberrancy:
- RS interval <100ms in precordial leads
- AV dissociation absent
- Typical BBB morphology
Pitfalls to Avoid
Misdiagnosing SVT as sinus tachycardia
- Look for abrupt onset/offset and P wave morphology
Using verapamil/diltiazem in wide-complex tachycardias of uncertain origin
- May cause hemodynamic collapse in VT 1
Failing to recognize pre-excitation
- Delta waves may be subtle
- Avoid AV nodal blockers alone in WPW
Overlooking underlying causes
- Thyroid disease, anemia, infection, heart failure
- Electrolyte abnormalities
Delaying referral for definitive treatment
Shared decision-making is essential when determining the optimal management strategy, considering the patient's preferences, frequency of episodes, symptom severity, and quality of life impact 1.